Solicitation - Notice of Intent to SS.pdf
PDF 70 KB Posted
- Attached to
- DARS Laboratory Supplies Federal contract opportunity
- Solicitation number
- FDA-CDER-25-128746
About this file
This document is a Notice of Intent to Sole Source issued by the Food and Drug Administration (FDA) on July 9, 2025, for a Cannabis Policy Study contract (FDA_CDER128746). The FDA intends to award a Firm Fixed Price contract to Fisher Scientific Company, LLC, located in Hanover Park, Illinois, under FAR Part 6.302-1, which allows for a sole source procurement when only one responsible source can satisfy agency requirements.
The notice provides an opportunity for other organizations to submit written capability statements demonstrating their ability to meet the contract requirements by July 18, 2025, at 3:00 PM EST. While the FDA anticipates awarding the contract to Fisher Scientific Company within ten days, they will review any submitted capability statements to determine if the procurement should be competed. Interested parties must email their capability statements to Hilda Aryeh at hilda.aryeh@fda.hhs.gov, with specific details to be found in the attached Statement of Work.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Attachment 3 Deliverables Thermo Fisher Scientific.pdf | ||
| Other_Attachment No. 2 - HHS Class Deviation.pdf | ||
| SOW FDA-CDER-25-128746.pdf | ||
| Other_Attachment No. 1 - FAR Class Deviation.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
July 9, 2025
Notice of Intent to Sole Source
Cannabis Policy Study
FDA_CDER128746
The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to Fisher
Scientific Company, LLC., 4500 Turnberry Dr., Hanover Park, Ill 60133-5491
In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.
MINIMUM REQUIREMENTS:
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the
Government.
It is anticipated that an award will be issued to Fisher Scientific Company, LLC. within approximately ten
(10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: July 18, 2025, by 3.00PM EST. Please email responses to Hilda Aryeh – hilda.aryeh@fda.hhs.gov.
Rodney D. Aytch
Contract Specialist mailto:hilda.aryeh@fda.hhs.gov
File details come from the government source that posted it. Updated .